Global Femtech Platform · Building on 5 years of femtech experience

A new chapter
for women's health
innovation.

For five years, the Tech4Eva initiative has explored what it takes to bring femtech innovation into healthcare. Today, we are taking that experience into a new, independent chapter.

Five years of impact · 2021–2025*

110+
Startups supported
CHF 294M
Raised by alumni co.
8 000+
Community reached

*Cumulative results from the prior accelerator program.

Tech4Eva — women's health innovation

Tech4Eva is an independent femtech platform. The previous accelerator program (2021–2025) was conducted by previous institutional partners and is no longer active. The new Tech4Eva builds on this experience as a separate, independently-governed initiative.

What's next

Implementation.
Validation.
Impact.

The next chapter of Tech4Eva is built on a simple conviction: real impact in women's health requires more than great ideas — it requires clinical proof, operational readiness, and investor-grade validation.

We are designing the next chapter around these principles. Stay connected — the announcement is coming soon.

Clinical-grade validation We will work with startups that have demonstrated real-world implementation in a clinical or operational setting.
Tech4Eva Impact Score A proprietary scoring framework, in design, to benchmark Femtech solutions across health economics, operational acceptance, and scalability.
Curated investor access We will connect validated startups with a global network of family offices, VCs, and strategic partners focused on women's health.

A differentiating principle, in design

The Tech4Eva Impact Score

We are designing a rigorous, standardised framework to evaluate Femtech solutions beyond the pitch deck. The Tech4Eva Impact Score will assess every startup across three critical axes — designed to give investors the confidence they need, and startups the validation they deserve.

01

Health Economics

Does the solution generate measurable economic value for the healthcare system? We will quantify cost savings, return on investment, and long-term impact on chronic disease prevention — the language investors and payers speak.

ROICost per outcomePayer readiness
02

Operational Acceptance

Is the solution actually used — by patients and by healthcare professionals? We will measure real-world adoption, retention, and the reduction of clinical workload, because a solution that isn't used creates no value.

RetentionClinical adoptionUser engagement
03

Scalability

Can the solution grow without proportionally growing its costs or complexity? We will evaluate operational autonomy, technology readiness, and the ability to expand across geographies and health systems.

Tech maturityOperational autonomyMarket readiness

A new chapter, designed around what really matters in women's health innovation.

Want to be among the first to know? Register your interest below.

Join the next chapter

Stay ahead of
what's coming.

Whether you're building a Femtech solution or looking for your next investment,
register your interest and be the first to hear from us.